On April 12, 2019, Governor Murphy signed into law the Aid in Dying for the Terminally Ill Act (the “Act”), which will become effective on August 1, 2019. NJ has become the eighth state to enact legislation to allow a qualified, terminally ill patient who is protected by safeguards to obtain medication that the patient chooses to self-administer in order to bring about the patient’s humane and dignified death. This new legislation has major implications for all physicians caring for terminally ill patients who are NJ residents, as defined by the law.
The Act defines the process to . . .
This content is for Conventus Insured Members only.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.